Literature DB >> 32441027

A bridge too far? Attempting to bridge the treatment gap in osteoporosis.

Bart L Clarke1, Dolores M Shoback2.   

Abstract

Entities:  

Keywords:  BMD; DXA; FRAX; Fracture; Osteoporosis; Treatment gap

Mesh：

Year:  2020        PMID： 32441027      PMCID： PMC8832363          DOI： 10.1007/s12020-020-02346-w

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  8 in total

1.  Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition.

Authors:  Robert B Conley; Gemma Adib; Robert A Adler; Kristina E Åkesson; Ivy M Alexander; Kelly C Amenta; Robert D Blank; William Timothy Brox; Emily E Carmody; Karen Chapman-Novakofski; Bart L Clarke; Kathleen M Cody; Cyrus Cooper; Carolyn J Crandall; Douglas R Dirschl; Thomas J Eagen; Ann L Elderkin; Masaki Fujita; Susan L Greenspan; Philippe Halbout; Marc C Hochberg; Muhammad Javaid; Kyle J Jeray; Ann E Kearns; Toby King; Thomas F Koinis; Jennifer Scott Koontz; Martin Kužma; Carleen Lindsey; Mattias Lorentzon; George P Lyritis; Laura Boehnke Michaud; Armando Miciano; Suzanne N Morin; Nadia Mujahid; Nicola Napoli; Thomas P Olenginski; J Edward Puzas; Stavroula Rizou; Clifford J Rosen; Kenneth Saag; Elizabeth Thompson; Laura L Tosi; Howard Tracer; Sundeep Khosla; Douglas P Kiel
Journal:  J Bone Miner Res       Date:  2019-12-01       Impact factor: 6.741

2.  Addressing the Crisis in the Treatment of Osteoporosis: A Path Forward.

Authors:  Sundeep Khosla; Jane A Cauley; Juliet Compston; Douglas P Kiel; Clifford Rosen; Kenneth G Saag; Elizabeth Shane
Journal:  J Bone Miner Res       Date:  2016-12-29       Impact factor: 6.741

Review 3.  Osteoporosis.

Authors:  Juliet E Compston; Michael R McClung; William D Leslie
Journal:  Lancet       Date:  2019-01-26       Impact factor: 79.321

4.  Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline.

Authors:  Richard Eastell; Clifford J Rosen; Dennis M Black; Angela M Cheung; M Hassan Murad; Dolores Shoback
Journal:  J Clin Endocrinol Metab       Date:  2019-05-01       Impact factor: 5.958

5.  Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures: An Instrumental Variable Analysis.

Authors:  Rishi J Desai; Mufaddal Mahesri; Younathan Abdia; Julie Barberio; Angela Tong; Dongmu Zhang; Panagiotis Mavros; Seoyoung C Kim; Jessica M Franklin
Journal:  JAMA Netw Open       Date:  2018-07-06

6.  Fracture liaison services improve outcomes of patients with osteoporosis-related fractures: A systematic literature review and meta-analysis.

Authors:  Chih-Hsing Wu; Shih-Te Tu; Yin-Fan Chang; Ding-Cheng Chan; Jui-Teng Chien; Chih-Hsueh Lin; Sonal Singh; Manikanta Dasari; Jung-Fu Chen; Keh-Sung Tsai
Journal:  Bone       Date:  2018-03-16       Impact factor: 4.398

7.  Anti-Osteoporosis Medication Prescriptions and Incidence of Subsequent Fracture Among Primary Hip Fracture Patients in England and Wales: An Interrupted Time-Series Analysis.

Authors:  Samuel Hawley; Jose Leal; Antonella Delmestri; Daniel Prieto-Alhambra; Nigel K Arden; Cyrus Cooper; M Kassim Javaid; Andrew Judge
Journal:  J Bone Miner Res       Date:  2016-07-04       Impact factor: 6.741

8.  Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011.

Authors:  Daniel H Solomon; Stephen S Johnston; Natalie N Boytsov; Donna McMorrow; Joseph M Lane; Kelly D Krohn
Journal:  J Bone Miner Res       Date:  2014-09       Impact factor: 6.741
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.